Publications:

Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells.

Plos One

Nigam, Nupur N; Grover, Abhinav A; Goyal, Sukriti S; Katiyar, Shashank P SP; Bhargava, Priyanshu P; Wang, Pi-Chao PC; Sundar, Durai D; Kaul, Sunil C SC; Wadhwa, Renu R

Publication Date: 2015

Variant appearance in text: p53: Q331A

PubMed Link: 26376435

Variant Present in the following documents:

• Main text
• pone.0138192.pdf

View BVdb publication page

Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations.

Genome Biology

Martelotto, Luciano G LG; Ng, Charlotte Ky CK; De Filippo, Maria R MR; Zhang, Yan Y; Piscuoglio, Salvatore S; Lim, Raymond S RS; Shen, Ronglai R; Norton, Larry L; Reis-Filho, Jorge S JS; Weigelt, Britta B

Publication Date: 2014-10-28

Variant appearance in text: TP53: Q331A

PubMed Link: 25348012

Variant Present in the following documents:

• 13059_2014_484_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

Intermolecular β-strand networks avoid hub residues and favor low interconnectedness: a potential protection mechanism against chain dissociation upon mutation.

Plos One

Feverati, Giovanni G; Achoch, Mounia M; Vuillon, Laurent L; Lesieur, Claire C

Publication Date: 2014

Variant appearance in text: p53: Q331A

PubMed Link: 24733378

Variant Present in the following documents:

• Main text
• pone.0094745.pdf

View BVdb publication page

Parallel analysis of tetramerization domain mutants of the human p53 protein using PCR colonies.

Genomic Medicine

Merritt, Joshua J; Roberts, Kim G KG; Butz, James A JA; Edwards, Jeremy S JS

Publication Date: 2007

Variant appearance in text: p53: Gln331Ala

PubMed Link: 18923936

Variant Present in the following documents:

• Main text

View BVdb publication page